Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.

Author(s)
Chow, Clara K
Klimis, Harry
Thiagalingam, Aravinda
Redfern, Julie
Hillis, Graham S
Brieger, David
Atherton, John
Bhindi, Ravinay
Chew, Derek P
Collins, Nicholas
Andrew Fitzpatrick, Michael
Juergens, Craig
Kangaharan, Nadarajah
Maiorana, Andrew
McGrady, Michele
Poulter, Rohan
Shetty, Pratap
Waites, Jonathon
Hamilton Craig, Christian
Thompson, Peter
Stepien, Sandrine
Von Huben, Amy
Rodgers, Anthony
Publication Date
2022-05-10
Abstract
BACKGROUND: TEXTMEDS (Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome) examined the effects of text message-delivered cardiac education and support on medication adherence after an acute coronary syndrome. METHODS: TEXTMEDS was a single-blind, multicenter, randomized controlled trial of patients after acute coronary syndrome. The control group received usual care (secondary prevention as determined by the treating clinician); the intervention group also received multiple motivational and supportive weekly text messages on medications and healthy lifestyle with the opportunity for 2-way communication (text or telephone). The primary end point of self-reported medication adherence was the percentage of patients who were adherent, defined as >80% adherence to each of up to 5 indicated cardioprotective medications, at both 6 and 12 months. RESULTS: A total of 1424 patients (mean age, 58 years [SD, 11]; 79% male) were randomized from 18 Australian public teaching hospitals. There was no significant difference in the primary end point of self-reported medication adherence between the intervention and control groups (relative risk, 0.93 [95% CI, 0.84-1.03]; P=0.15). There was no difference between intervention and control groups at 12 months in adherence to individual medications (aspirin, 96% vs 96%; β-blocker, 84% vs 84%; angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, 77% vs 80%; statin, 95% vs 95%; second antiplatelet, 84% vs 84% [all P>0.05]), systolic blood pressure (130 vs 129 mm Hg; P=0.26), low-density lipoprotein cholesterol (2.0 vs 1.9 mmol/L; P=0.34), smoking (P=0.59), or exercising regularly (71% vs 68%; P=0.52). There were small differences in lifestyle risk factors in favor of intervention on body mass index <25 kg/m(2) (21% vs 18%; P=0.01), eating ≥5 servings per day of vegetables (9% vs 5%; P=0.03), and eating ≥2 servings per day of fruit (44% vs 39%; P=0.01). CONCLUSIONS: A text message-based program had no effect on medical adherence but small effects on lifestyle risk factors. REGISTRATION: URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448; Unique identifier: ANZCTR ACTRN12613000793718.
Affiliation
Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.
Department of Cardiology, Westmead Hospital, Sydney, Australia (C.K.C., H.K., A.T.).
Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.
University of Western Australia, Perth (G.S.H., P.T.).
Department of Cardiology, Royal Perth Hospital, Australia (G.S.H.).
ANZAC Research Institute (D.B.), University of Sydney, Australia.
Department of Cardiology, Royal Brisbane and Women's Hospital, Brisbane, Australia (J.A.).
The University of Queensland, Brisbane, Australia (J.A., C.H.C.).
Department of Cardiology, Royal North Shore Hospital, Sydney, Australia (R.B.).
College of Medicine and Public Health, Flinders University, Adelaide, South Australia (D.P.C., N.K.).
Hunter Medical Research Institute, Newcastle, Australia (N.C.).
Faculty of Medicine, The University of New South Wales, Sydney, Australia (C.J.).
Department of Cardiology, Liverpool Hospital, Sydney, Australia (C.J.).
Department of Cardiology, Royal Darwin Hospital, Darwin, Australia (N.K.).
Menzies School of Health Research, Darwin, Australia (N.K.).
Allied Health Department, Fiona Stanley Hospital, Perth, Australia (A.M.).
School of Allied Health, Curtin University, Perth, Australia (A.M.).
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (M.M.).
Department of Cardiology, Sunshine Coast University Hospital, Brisbane, Australia (R.P.).
Department of Cardiology, Wollongong and Shellharbour Hospitals, Wollongong, Australia (P.S.).
Coffs Cardiology, Coffs Harbour, Australia (J.W.).
Department of Cardiology, Prince Charles Hospital, Brisbane, Australia (C.H.C.).
Department of Cardiology, Sir Charles Gairdner Hospital, Perth, Australia (P.T.).
Harry Perkins Institute of Medical Research, Perth, Australia (P.T.).
The George Institute for Global Health, Sydney, Australia (C.K.C., H.K., A.R., G.S.H., S.S., A.R.).
Citation
Circulation. 2022 May 10;145(19):1443-1455. doi: 10.1161/CIRCULATIONAHA.121.056161. Epub 2022 May 9.
OrcId
0000-0003-4693-0038
0000-0002-3635-421X
0000-0001-8707-5563
0000-0003-2417-4673
0000-0001-6115-0326
0000-0003-3593-296X
0000-0002-0681-1707
0000-0002-6561-7496
0000-0001-6168-9719
Pubmed ID
https://pubmed.ncbi.nlm.nih.gov/35533220/?otool=iaurydwlib
Link
Volume
145
Subject
*Acute Coronary Syndrome/drug therapy/prevention & control
Australia
Female
Humans
Male
Medication Adherence
Middle Aged
Secondary Prevention
Single-Blind Method
*Text Messaging
Title
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.
Type of document
Journal Article
Entity Type
Publication

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/1bb55800-8da9-43cc-8082-809ef105dece